Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?
Psilocybin, a drug most commonly recognized as a recreational psychedelic, is quickly gaining attention as a promising therapy for an expanding range of neurological conditions, including depression, anxiety, and addiction. This growing interest has led to many recent advancements in psilocybin synt...
Guardado en:
Autores principales: | William J. Gibbons, Madeline G. McKinney, Philip J. O’Dell, Brooke A. Bollinger, J. Andrew Jones |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8bd116372e74aefb9a4cdaa8d2ccdf3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
por: Manoj K. Doss, et al.
Publicado: (2021) -
Impact of lipopolysaccharides on cultivation and recombinant protein expression in human embryonal kidney (HEK‐293) cells
por: Christine Faust, et al.
Publicado: (2021) -
Robust Agrobacterium-Mediated Transient Expression in Two Duckweed Species (Lemnaceae) Directed by Non-replicating, Replicating, and Cell-to-Cell Spreading Vectors
por: Anton Peterson, et al.
Publicado: (2021) -
Channelling carbon flux through the meta‐cleavage route for improved poly(3‐hydroxyalkanoate) production from benzoate and lignin‐based aromatics in Pseudomonas putida H
por: José Manuel Borrero‐de Acuña, et al.
Publicado: (2021) -
Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead
por: Martin L. Williams, et al.
Publicado: (2021)